Moberg Pharma AB (OMX: MOB) and Allderma today announce that the launch of Terclara® (MOB-015) is ongoing in Norway. The launch marks an important step in both companies' commercial strategy and ...
Fox Factory Holding Corp. (Nasdaq: FOXF) (the “Company”), a premium brand and a global leader in the design, engineering and manufacturing of performance-defining products and systems for customers ...
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention ...
Dover Corporation (NYSE: NYSE:DOV), a diversified global manufacturer of innovative equipment, components, and systems, has ...
DULUTH, Ga., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Fox Factory Holding Corp. (Nasdaq: FOXF) (the “Company”), a premium brand and a global leader in the design, engineering and manufacturing of ...
Roper Technologies, Inc. (NASDAQ:ROP), a diversified technology company specializing in software and engineered products for niche markets with a market capitalization of $61.88 billion, has been the ...
Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya vaccine is expected to launch in key European markets in ...
Revenue was up by 26% in Q2 2024/25 to DKK 135.9 million from DKK 108.1 million in the year-earlier period. In the first half ...
Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older
COPENHAGEN, Denmark, January 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA ...
BIOHIT Oyj is excited to announce the launch of the BIOHIT FAEX Sample System, a revolutionary stool sample collection and handling solution that can be seamlessly incorporated into any diagnostic ...
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results